Felipe Emilio Dominguez
Pathology - Clinical Pathology β’ Melbourne, FL
3030 Venture Ln, Ste. 108
Melbourne, FL 329348172
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Felipe Dominguez is listed in NPPES under Pathology - Clinical Pathology.
-
NPI assigned on March 29, 2007; this date does not establish years in practice.
-
Published CMS data list 12 Medicare Part D prescriptions, including refills, in 2020.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2020. Published rows only; this is not a quality measure.
-
Published Part D records, 2020:
- Invokana (Canagliflozin) β 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2020. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table Β· Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 11 in 2018 to 12 in 2020.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2018β2020.
Practice Location & Contact Primary Location
3030 Venture Ln
Ste. 108
Melbourne, FL 329348172
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Pathology - Clinical Pathology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
12 standardized 30-day fills in 2020
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$6,535 in 2020
The total cost of these prescriptions in 2020, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2020.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $21.35 in 2022
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2022.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Felipe Dominguez has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Felipe Dominguez as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Melbourne and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Felipe Dominguez are from 2020.
1 active clinicians are listed under Pathology - Clinical Pathology with a practice address in Melbourne, FL (21 in Florida).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions went from 11 in 2018 to 12 in 2020.
- 2018: 11
- 2020: 12
-
30-day fills
30-day fills went from 11 in 2018 to 12 in 2020.
- 2018: 11
- 2020: 12
-
Part D drug cost
Part D drug cost increased 22% from $5,369 in 2018 to $6,535 in 2020.
- 2018: $5,369
- 2020: $6,535
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2022 only.
Sources: CMS Medicare Part D Prescribers (2020), CMS Open Payments (2022), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2022 (payments made January 1 β December 31, 2022): fewer than 11 records totaling $21.35.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Vericel Corporation |
Food and Beverage
In-kind items and services
|
MACI | General | $21.35 |
Source: CMS Open Payments, program year 2022, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2020.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Invokana | Canagliflozin | 12 | 360 | $6,534.64 | β |
Source: CMS Part D by Provider and Drug, 2020; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-11-10NUCC Taxonomy Code: 291U00000X
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
NUCC Taxonomy Code: 207ZC0006X
A pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PATHOLOGY
I20080818000315
FL
6507948502
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Recorded as FELIPE DOMINGUEZ
Pathology (license number reported to NPPES: FL ME48985)
Registered at 3030 VENTURE LN, STE 108, MELBOURNE, FL 329348172 (Tel: 3212535197)
NPI status registered as active in NPPES database
Registered at 3030 VENTURE LN, STE. 108, MELBOURNE, FL 329348172 (Tel: 3212535197)
Registered at 2800 AURORA RD, STE I, MELBOURNE, FL 329352096 (Tel: 3212535197)
Recorded as FELIPE DOMINGUEZ, MD
Clinical Medical Laboratory (license number reported to NPPES: FL ME 48985)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
3030 Venture Ln, Ste 108
Melbourne, FL 329348172
Phone: 3212535197